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Abstract
 
Escape mutations are believed to be important contributors to immune evasion by rapidly
evolving viruses such as hepatitis C virus (HCV). We show that the majority of HCV-specific
cytotoxic T lymphocyte (CTL) responses directed against viral epitopes that escaped immune
recognition in HCV-infected chimpanzees displayed a reduced CDR3 amino acid diversity
when compared with responses in which no CTL epitope variation was detected during
chronic infection or with those associated with protective immunity. Decreased T cell receptor
(TCR) CDR3 amino acid diversity in chronic infection could be detected long before the
appearance of viral escape mutations in the plasma. In both chronic and resolved infection,
identical T cell receptor clonotypes were present in liver and peripheral blood. These findings
provide a deeper understanding of the evolution of CTL epitope variations in chronic viral
infections and highlight the importance of the generation and maintenance of a diverse TCR
repertoire directed against individual epitopes.
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Introduction
 
Strong hepatitis C virus (HCV)–specific CD4
 
 
 
 and CD8
 
 
 
T cell responses against multiple viral epitopes have been
associated with clearance of HCV during acute infection
(1–6) and are thought to be important contributors to pro-
tective immunity (7–9). Failure to eradicate the virus despite
detectable CTL responses has been associated with emergence
of viral escape mutations within epitopes targeted by CTLs
during acute HCV (10, 11) and several other viral infections
(12–15). Maturation defects or functional impairment of
antigen-specific CTL responses have been observed by sev-
eral investigators and are thought to be possible reasons
for viral persistence despite measurable T cell responses in
HCV (16–19). T cell receptor diversity against viral epi-
topes may be another factor that influences the outcome of
viral infection.
In various chronic viral and intracellular infections, antigen-
specific T cell responses are characterized by a marked
structural TCR diversity (20–23). The majority of expanded
CD8
 
 
 
 T cells during acute lymphocytic choriomeningitis
virus infection are pathogen specific (24), and many of
these initially expanded CD8
 
 
 
 T cells undergo apoptosis
(25, 26), leaving behind a stable pool of memory cells with
structural and functional resemblance to the primary T cell
response (27, 28). This contrasts findings in some experimental
models where repeated rechallenge with antigen results in a
narrowing of the antigen-specific T cell receptor repertoire,
probably caused by a selective expansion of high affinity T
cell clones (29–32). However, after simian immunodefi-
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ciency virus infection of rhesus macaques, fluctuations
within the TCR repertoire, but no evidence of a matura-
tion of the TCR repertoire, could be observed over the
course of infection (33). It has been hypothesized that in
chronic viral infections characterized by high viral muta-
tion rates, the generation and maintenance of a highly di-
verse epitope-specific TCR repertoire might decrease the
chance of CTL escape due to cross-recognition of mutated
epitopes (34–36). The benefit of TCR diversity is also sup-
ported by studies demonstrating that a diverse TCR reper-
toire is more likely to contain high affinity T cell clones
that results in better epitope recognition and control of the
pathogen (32, 33, 37). This view is also supported by rapid
evolution of viral escape mutations associated with a nar-
row response against a single CTL epitope in HIV infec-
tion (38) and deletions of the HIVnef gene after infusion of
CTL clones against a single viral epitope in HIV infection
(39). However, to date, there is no convincing evidence
linking the TCR diversity of virus-specific T cells with
evolution of CTL escape mutations in a chronic viral infec-
tion in vivo.
Structural analyses of the TCR–pMHC complex high-
light the importance of the CDR3 region as a dominant
antigen recognition site within the TCR (40). Here, we
tested the hypothesis that in vivo–generated T cell re-
sponses that induce CTL escape are more likely to display a
narrow CDR3 repertoire as compared with T cell re-
sponses where no CTL epitope variation occurs or to those
that are found in protective immunity. We took advantage
of the chimpanzee HCV disease model in which all animals
were infected with the same HCV-1/910 virus inoculum
(10), eliminating the problem of infection with variant vi-
ruses, which is unavoidable in human studies of HCV in-
fection. Some of the infected chimpanzees resolved the
infection spontaneously (2), even after homologous rechal-
lenge (9), whereas others developed persistent disease de-
spite existing CTL responses (41). In chronically infected
animals, detectable T cell responses were found in the liver
and the peripheral blood (2, 10, 41, 42), and they were as-
sociated with the evolution of escape mutations in almost
all of the targeted epitopes (for an overview of analyzed
immune responses and CTL epitope variations, see Table I;
references 11, 42). To assess the diversity of HCV-specific
T cell responses, we used a recently published method that
allows the generation of a high number of antigen-specific
TCR sequences (43–45). In addition, we performed TCR
 
 
 
/
 
 
 
sequence analysis of HCV-specific T cell clones derived
by limiting dilution from the liver or blood of the infected
animals.
 
Materials and Methods
 
Subjects. 
 
Infection of the chimpanzees enrolled in this study
with the HCV-1/910 virus stock has been described in detail
previously (2, 10, 11, 46, 47). CBO572 was initially infected
with 100 CID of HCV-1/910 stock and rechallenged 7 yr later
with the same virus (9). CBO603 and CH-503 have been chron-
ically infected for 7 or 9 yr, respectively. Chimpanzees were
housed at the New Iberia Research Center. Animals were cared
for under an experimental protocol approved by the New Iberia
Research Center Animal Care and Use Committee.
 
Cell Lines. 
 
CTL lines were derived from liver biopsy tissue
as described previously (10). In brief, after homogenization of
liver biopsies, CD8
 
 
 
 T cells were enriched using anti–human
CD8
 
 
 
 dynabeads (Dynal) and cultured at 10–50 cells per well in
a 96-well tissue culture plate in the presence of anti–human CD3
(Immunotech), irradiated human PBMCs, and R10 medium sup-
plemented with 50 U/ml rIL-2. At least 300 independently de-
rived CD8
 
 
 
 T cell lines were tested for recognition of autologous
B cell target cells infected with recombinant vaccinia viruses ex-
pressing different regions of the HCV-1/910 polyprotein. HCV-
specific CD4
 
 
 
 and CD8
 
 
 
 T cells were enriched from peripheral
blood after Ficoll-Paque (Amersham Biosciences) by culturing
20–40 
 
 
 
 10
 
6
 
 PBMCs with the respective HCV peptide (50 
 
 
 
M).
Cells were restimulated on days 7 and 14 with 2 
 
 
 
 10
 
6
 
 irradiated
autologous PBMCs pulsed with 50 
 
 
 
M of the peptide. Analysis
of peptide-specific IFN-
 
 
 
 production and purification of IFN-
 
 
 
 
 
cells was performed between days 21 and 25.
 
Purification of HCV-specific Cells by IFN-
 
 
 
 Secretion. 
 
IFN-
 
 
 
 
 
HCV-specific T cells were purified using a cytokine-secretion as-
say (Miltenyi Biotec) as described previously (44) with minor
modifications. In brief, 30–40 
 
 
 
 10
 
6
 
 T cells were incubated with
20 
 
 
 
M peptide and 1 
 
 
 
g/ml of the anti-CD28 and anti-CD49d
mAbs (Becton Dickinson) at 37
 
 
 
C, 5% CO
 
2
 
 for 6–8 h. Subse-
quently, IFN-
 
 
 
 
 
 cells were stained with monoclonal antibodies
according to the manufacturer’s protocol (Miltenyi Biotec) and
separated by cell sorting using the FACSvantage™ cell sorter
(Becton Dickinson). In all experiments, the purity of the en-
riched populations was 
 
 
 
90% (range 90–99%). FACS
 
®
 
 data on
representative purifications are provided in Fig. S1, available at
http://www.jem.org/cgi/content/full/jem.20040638.
 
cDNA Synthesis and TCR Sequencing. 
 
A modified anchored
RT-PCR was performed with Powerscript Reverse transcriptase
(CLONTECH Laboratories, Inc.) from total RNA as described
previously (43, 44) using gene-specific primers for the TCR
 
 
 
constant region or the 
 
 
 
 constant region with a modified cDNA
anchor primer (CLONTECH Laboratories, Inc.). Amplification
of the cDNA by PCR was performed using the TCR constant
region based primers and an anchor-specific primer 5
 
 
 
-AATC-
CTTTCTCTTGACCATG-3
 
 
 
. PCR products of 500–600 base
pairs were gel purified and cloned using the TOPO TA cloning
kit (Invitrogen). Selected colonies were sequenced using the Taq
DyeDeoxy Terminator cycle sequencing kit (Applied Bio-
systems) and capillary electrophoresis on a PRISM auto-
mated sequencer (Applied Biosystems). Full-length sequences of
all TCR
 
 
 
 variable regions have been published previously (44)
and have been submitted to GenBank/EMBL/DDBJ (accession
nos. AY168667 and AY168708).
 
CTL Assays. 
 
Autologous lymphoblastoid B cell lines were
used as targets and incubated with 50 
 
 
 
Ci of 
 
51
 
Cr and varying
concentrations of the respective peptide epitopes. After washing
5 
 
 
 
 10
 
3
 
 target, cells were cocultured with effector CTL lines at
different effector/target ratios for 4 h. 50 
 
 
 
l of supernatant was
harvested into Lumaplates (Packard Instrument Co.) and radioac-
tivity was counted in a Microbeta scintillation instrument (Wal-
lac). To determine the binding kinetics of variant and wild-type
peptides, we analyzed CTL clone recognition of peptide-pulsed
target cells over a 48-h period. B cell lines were first pulsed with
100 
 
 
 
M of the variant or the wild-type peptide. CTL recogni-
tion was measured with the standard chromium release assay as
aforementioned at hours 0, 16, and 48. 
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Entropy Calculations and Statistical Analysis. 
 
Genetic analysis
was performed as described previously (44). In brief, after align-
ment of sequences, amino acid variability was determined using
the Shannon entropy (
 
H
 
; reference 48) calculation for protein sites
as described previously (49) by the formula: 
 
H 
 
    
 
 
 
p
 
i 
 
log
 
2
 
 
 
p
 
i
 
where 
 
p
 
i
 
 is the fraction of residues at a site that is amino acid type
 
i
 
. For the 20 amino acids, 
 
H
 
 can range from 0 (site contains only
one amino acid in all sequences) to 4.32 (all amino acids are repre-
sented equally at this site). Positions that contained 
 
 
 
50% gaps
were excluded from analysis. Statistical analyses were performed
with Prism 3.0 (GraphPad Software Inc.), Version 11.0. (SPSS
Inc.), and Version 8.02 (SAS Institute). Mann-Whitney U tests
were used to compare distributions of entropy values between re-
sponses, and the Wilcoxon Sign test was used to compare within
Figure 1. TCR /  repertoire
of liver-derived HCV-specific
CD8  T cells targeting CTL
epitopes undergoing escape mu-
tations in chronically infected
chimpanzees. (A) TCR /  rear-
rangements of HCV-specific,
liver-derived CD8  T cell clones
in chimpanzee CBO603 directed
against NS41963. (B) TCR  / 
rearrangements of HCV-specific,
liver-derived CD8  T cell clones
in chimpanzee CH-503 directed
against NS51989. T cell clones with
identical nucleotide sequences in
TCR  and TCR  are identified
with symbols (*, §) at the end of
the sequence.
 
Table I.
 
HCV-1 Epitopes and Disease Status of Study Animals
 
Animal Patr allele HCV region
Wild-type sequence/
escape mutations Month of detection Status
CBO603 A
 
*
 
0901 NS4
 
1963–1972
 
QWISSECTTPC/
----------- (8/24)
------S---- (2/24)
--L-----A—- (1/24)
--L-------- (13/24)
 
63
 
a
 
chronic
CH-503 A
 
*
 
0401 E2
 
588–596
 
KHPDATYSR/
-------T- (9/9)
 
21 chronic
B
 
*
 
1601 E1
 
233–241
 
GNASRCWVA/
--------- (15/15)
 
NA
NS3
 
1446–1454
 
GDFDSVIDC/
---E----- (10/10)
 
3
NS5a
 
1989–1997
 
SDFKTWLKA/
---R----- (11/11)
 
10
CBO572 B
 
*
 
2302 E2
 
445–456
 
HKFNSSGCPERL/
NA
 
NA resolved
DRB1
 
*
 
1001 NS3
 
1248–1257
 
GYKVLVNPSV/
NA
 
NA
DRB5
 
*
 
0310 NS3
 
1380–1389
 
YGKAIPLEVI/
NA
 
NA
 
a
 
 No sequencing performed between months 4 and 63 (reference 11). 
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epitope difference between memory and rechallenged entropy
values of the E2
 
445 peptide. A linear mixed regression was used to
compare entropy values by escape from immune recognition. The
use of a mixed regression model controls for dependency among
entropy values within a response.
Online Supplemental Material.  IFN-  production of expanded
HCV-specific T cells derived from CH-503 and purity after en-
richment using FACS® are shown in Fig. S1. Online supplemen-
tal material is available at http://www.jem.org/cgi/content/full/
jem.20040638.
Results
TCR /  Repertoire of CD8  T Cell Clones Directed
against HCV Epitopes Undergoing Escape Mutations. Our
initial studies identified a narrow spectrum of TCR usage
from CTL clones isolated from the liver of infected
chimpanzees. In two chronically infected chimpanzees
(CBO603 and CH-503), we were able to isolate multiple
T cell clones from the liver after 5 yr of persistent viremia
that targeted identical CTL epitopes (Fig. 1). These clones
targeted the NS41963 and NS51989 epitopes in CBO603 and
CH-503, respectively (Table I). At the time of isolation of
these CTL clones, viral escape mutations within these
epitopes were found in the plasma of both chimpanzees as
described previously (Table I and reference 11), and none
of these CTL clones was able to recognize the variant
epitope sequences (unpublished data). TCR /  analysis
demonstrated common variable and joining region usage
by most of the clones as well as highly homogenous CDR3
amino acid motifs present in most of the TCR  and
TCR  chain sequences (Fig. 1). These data indicate that
CTL escape mutations may be associated with the presence
of a highly uniform TCR /  repertoire.
Longitudinal Analysis of the TCR Repertoire Associated with
CTL Escape. CH-503 recognized another viral epitope
located within the HCV envelope protein 2 (E2588/ 588-
KHPDATYSR-596 ) early after primary infection (11).
CD8  T cell clones targeting that epitope were isolated
from the liver of CH-503 at multiple time points after in-
fection. A single viral escape mutation (S595T) within this
epitope was found as early as 21 mo after infection and re-
mained present as the dominant clone in the viral popula-
tion thereafter (Table I and reference 11). All liver-derived
E2588-specific CTL clones isolated at 7 mo after infection,
14 mo before detection of the escape mutation in the
plasma, used similar variable and joining regions, and, more
importantly, displayed a highly homologous amino acid
motif within their CDR3 region in both TCR  and
TCR  chains (Fig. 2 A). 7 yr after primary infection and 5
yr after the viral escape occurred, nearly identical amino
Figure 2. Longitudinal analysis
of the TCR /  repertoire of
HCV-E2588–specific CD8  T cells
before and after the detection of
CTL epitope variations. (A) E2588-
specific T cells were derived
from the liver of chimpanzee
CH-503 7 mo after primary infec-
tion, but before the appearance of
escape mutations. (B) TCR / 
rearrangement of liver-derived T
cell clones generated by limiting
dilution 7 yr after primary infec-
tion. (C) PBMC-derived TCR 
clonotypes 9 yr after primary in-
fection. 67 sequences were eval-
uated at month 110, and 70 se-
quences were evaluated at month
112 after infection. Amino acid
motifs within the CDR3 antigen
recognition site are shown (bold).
Homogenous areas within the
CDR3 repertoire are indicated
(boxed). Gray areas indicate nu-
cleotide differences of clonotypes
with identical amino acid motifs.
T cell clones with identical nu-
cleotide sequences in TCR  and
TCR  are identfied with sym-
bols (*, **, §) at the end of the
sequence.Meyer-Olson et al. 311
acid motifs were detectable in the CDR3 regions of
TCR /  chains from liver-derived E2588-specific CTL
clones (Fig. 2 B). Interestingly, we observed that clono-
types with amino acid motifs identical to those observed 7
mo after primary infection displayed different nucleotide
sequences, indicating that those T cell clones were derived
from different T cell progenitors (Fig. 2, gray areas).
Because this response was also detectable in the periph-
eral blood, we analyzed a total of 137 TCR  rearrange-
ments from PBMC-derived CD8  T cells specific for E2588
at two independent time points 9 yr after primary infection
(Fig. 2 C). The TCR repertoire at both time points was
nearly identical, with  90% of sequences present on both
occasions and with a similar hierarchy of the individual
clonotypes, demonstrating the reproducibility of the results
(Fig. 2 C). The majority of clonotypes from peripheral
blood had highly similar amino acid motifs within their
CDR3 region as compared with clonotypes of liver-
derived T cell clones derived from earlier time points, some
with identical nucleotide sequences (Fig. 2). We observed
predominant recombination of T cell receptor   variable
(TRBV) region 30 with T cell receptor   joining (TRBJ)
region 1-1 in most of the sequences. Despite the high sim-
ilarity on the amino acid level, the T cell response detected
9 yr after primary infection contained many clonotypes that
were not previously detected. Interestingly, one clonotype
displayed a CDR3 region amino acid sequence that was
highly similar to the predominant CDR3 region sequence
that was found in clonotypes rearranging TRBV30 with
TRBJ1-1, but this clonotype used the TRBV7-2 variable
region (Fig. 2 C). Together, these data indicate that a re-
stricted TCR repertoire can be detected long before viral
escape mutations become evident and that new clonotypes
with identical or highly similar amino acid motifs within
the antigen recognition site can be detected over the course
of infection.
Analysis of the Entropy of HCV-specific TCR Repertoires.
To further evaluate and compare the degree of TCR di-
versity of different HCV-specific T cell responses, we com-
puted the Shannon entropy (48) for all amino acids sites
Figure 3. Analysis of amino acid diversity of the CDR3/joining region in HCV-specific T cell responses. Shannon entropies per amino acid site for
unselected T cells (A) and CD8  T cells specific for E2588 (B) and E1233 (C) in CH-503 are shown. (D–G) CD8  T cells specific for E2445 in CBO572 6
yr after resolution of primary infection (D) and 14 d after rechallenge with a homologous virus at the peak of the immune response (E), and for CD4  T
cells specific for NS31248 6 yr after resolution of primary infection (F) and 14 d after rechallenge with a homologous virus at the peak of the immune
response (G). Bar graphs indicate the entropy at the respective amino acid site. Conserved amino acid residues are shown (gray bars). Amino acid residues
are numbered starting with the conserved NH2-terminal cysteine of the TCR variable region.TCR Diversity and CTL Escape 312
within each response (Fig. 3). This method has been shown
to be useful in the quantification of amino acid diversity in
distinct regions of antigen receptors such as immunoglobu-
lins and TCRs (49). A highly diverse TCR repertoire was
observed within an unselected T cell population from CH-
503 (Fig. 3 A). In marked contrast, liver-derived CTL
clones from this animal specific for the NS51989 epitope
(Fig. 1 B), which mutated 10 mo after infection, displayed
a low CDR3 entropy value of 0.31   0.54. Similarly, the
entropy of the TCR sequences generated from six liver-
derived CTL clones specific for the E2588 epitope (isolated
before escape from immune recognition) was very low
(0.17   0.37), due to the presence of a dominant amino
acid motif within the CDR3 region (Fig. 2 A). The en-
tropy of a cell line specific for this same epitope generated
from PBMCs in month 110 (9 yr after viral escape) was still
low (0.45   0.28; P   0.02; Fig. 3 B) and far lower than
most responses associated with lack of escape. In this re-
sponse, 85% of the TCR sequences were comprised of a
single TCR clonotype, the majority of the remaining se-
quences used the BV30 gene and highly similar CDR3
region sequences, and 94% of the sequences contained
identical amino acid motifs (despite different nucleotide se-
quences) to those from liver-derived CTL clones (Fig. 2
C). A follow-up analysis of PBMCs from month 112 after
infection showed nearly identical results. There was no dif-
ference in entropy compared with the month 110 result,
and in this case 90% of sequences showed the same CDR3
amino acid motif associated with this immune response
(Fig. 2 C).
TCR Repertoire of HCV-specific Responses Directed against
an Epitope without CTL Epitope Variation. The entropy of
the E2588-specific CD8  T cell response was compared
with a CD8  T cell response derived from CH-503 that
was directed against the envelope protein 1 (Table I, E1233/
 GNASRCWVA ). This was the only epitope targeted by
the CD8  T cell response in this animal that showed no
evidence of viral escape throughout infection (11). Of 97
TCR sequences generated from PBMC-derived E1233-spe-
cific CD8  T cells specific for this epitope, we identified at
least 16 distinct TCR clonotypes with diverse TRBV- and
TRBJ-region usage (Fig. 4). The mean CDR3 entropy
value of this response was 2.14   0.91, which was signifi-
cantly higher than the entropy observed for the E2588-spe-
cific CD8  T cell response (P   0.002; Fig. 3 C). Thus,
we were able to identify and quantify differences between
the TCR repertoire diversity of CD8  T cell responses di-
rected against epitopes that underwent escape and those
that did not show CTL epitope variations during chronic
infection. These results also demonstrate that in this chron-
ically infected animal, a diverse repertoire could be gener-
ated after in vitro expansion for the one response not asso-
ciated with escape from immune recognition. For each of
these immune responses the level of circulating CTL was
low, yet epitope-specific CTLs were easily expanded from
peripheral blood, and made up 10–30% of cell lines as as-
sessed by intracellular IFN-  staining. There was no corre-
lation between the baseline levels of immune responses ex
vivo, the degree of in vitro expansion, and the CDR3
amino acid diversity for these responses (Fig. S1).
TCR Repertoire Associated with Resolved HCV Infection.
To determine whether our observations might have any
relevance for the outcome of HCV infection, we evaluated
the TCR diversity of T cell responses associated with
spontaneous clearance of hepatitis C. We characterized
the TCR repertoires of HCV-specific T cell responses in
CBO572, where we observed successful termination of the
primary HCV infection and accelerated viral clearance after
homologous rechallenge. A detailed description of these
immune responses has been recently published (Table I and
reference 9). The TCR repertoire of a dominant CD8  T
cell response (E2445/ 445-HKFNSSGCPERL-456 ; refer-
ence 9) from chimpanzee CBO572 at 6 mo before rechal-
lenge (6 yr after primary infection) and at day 14 after re-
challenge (at the peak of the immune response, when the
virus was cleared) was found to be highly diverse. Fig. 5 A
Figure 4. TCR  clonotypes in chronic in-
fection without CTL epitope variants. TCR 
clonotypes of E1233-specific CD8  cells derived
from the peripheral blood of CH-503, where no
escape was detectable during chronic infection.Meyer-Olson et al. 313
demonstrates the sequences and frequencies of the TCR 
clonotypes of E2445–specific CD8  T cells that were ob-
served during the memory phase of infection and after re-
challenge. Similar to previous findings in different infec-
tious models, the majority of E2445-specific CD8  T cell
sequences evaluated at the peak of the immune response
were identical to clonotypes detected within the prechal-
lenge memory repertoire (28). Moreover, clonotypes that
Figure 5. TCR clonotypes after resolved infection, and after rechallenge with homologous virus. (A) The majority of TCR  clonotypes of E2445-
specific CD8  T cells from CBO572 are identical before and after rechallenge. The frequencies of individual clonotypes 6 yr after resolved primary
infection (memory) and 14 d after rechallenge with homologous virus are shown. (B) TCR  rearrangement and CDR3 sequences of three CD8  T cell
clones derived from liver or PBMCs derived from CBO572 5 yr after primary infection. (C) T cell clones show E2445-specific cytotoxic activity as tested
in chromium release assay against autologous target cells at an effector/target cell ratio of 5:1.TCR Diversity and CTL Escape 314
were dominant during the memory phase of the infection
were also dominant at the peak of the immune response af-
ter rechallenge. TCR  sequences derived from E2445-spe-
cific CTL clones (Fig. 5 B), which were independently iso-
lated from the liver and peripheral blood of this animal 5 yr
after primary infection by limiting dilution, corresponded
to sequences within the TCR repertoire derived from T
cells expanded from PBMCs. HCV specificity of these T
cell clones was confirmed in a chromium release cytotoxic-
ity assay using E2445 peptide–pulsed autologous target cells
(Fig. 5 C). After rechallenge, the magnitude of this re-
sponse expanded dramatically (9). Within the population of
TCR sequences, the dominant TCR sequences from the
memory phase of infection showed a preferential expansion
after rechallenge. This was associated with a small but sta-
tistically significant decrease in the entropy value at each
amino acid position of the CDR3 region (P   0.002), and
with a similar pattern of entropy values at each amino acid
position (Fig. 3, D and E). Despite this decrease, the en-
tropy value after rechallenge was still higher than the ma-
jority of entropies observed in T cell responses associated
with CTL escape.
The TCR repertoires of two dominant CD4  T cell
responses directed against the HCV-nonstructural pro-
tein 3 (NS31248/ 1248-GYKVLVNPSV-1257  and NS31380/
 1380-YGKAIPLEVI-1389 ) also displayed a high degree
of CDR3 diversity. The highest level of clonal diversity in
CBO572 could be detected within the NS31248-specific
CD4  T cell response, where we analyzed the TCR reper-
toire of the memory response (before virus rechallenge; en-
tropy 2.3   1.14) and at the peak of the immune response
14 d after rechallenge (entropy 2.29   1.10; Fig. 3, F and
Figure 6. TCR clonotypes after resolved infection,
and after rechallenge with homologous virus. TCR 
clonotypes of NS31248-specific CD4  T cells from
CBO572 before and after rechallenge. The frequencies
of individual clonotypes 6 yr after resolved primary in-
fection (memory) and 14 d after rechallenge with ho-
mologous virus are shown. *, sequences with identical
CDR3 amino acid sequences, but rearrangement of
different variable regions.Meyer-Olson et al. 315
G, and Fig. 6). This polyclonal response was characterized
by rearrangement of genes from the TRBV5 family, but a
highly diverse CDR3 and joining region repertoire. After
rechallenge, there was no significant change in entropy, de-
spite a 10-fold increase in the magnitude of this response
(9). However, several new but closely related sequences
were detectable after rechallenge (Fig. 6). Again, we ob-
served the rearrangement of identical CDR3 sequences
with different yet closely related TRBV sequences, but no
evidence of somatic mutations within the antigen-specific
T cell receptor repertoire.
Low Entropies of HCV-specific T Cell Responses Are Associ-
ated with Immune Escape. Together, we observed striking
differences in TCR diversity between the majority of
HCV-specific responses directed against epitopes that un-
derwent CTL escape and those that were associated either
with no escape during chronic infection or with protective
immunity. Fig. 7 summarizes the hierarchies of the CDR3
entropy values analyzed in this paper. The highest entropy
values were present in the unselected T cells (2.53   0.96),
the two CD4  T cell responses, NS31380 (2.12   1.06) and
NS31248 (2.29   1.14), and the E1233 CD8  T cell re-
sponse (2.14   0.91). Each of these values was significantly
higher than three out of the four responses (NS41963,
NS51989, and E2588) associated with escape from immune
recognition (p-values range from  0.001 to 0.012 for each
comparison). In addition, the dominant CD8  T cell re-
sponse in chimpanzee CBO572, which was directed
against the E2445 epitope and had an entropy value of
1.49   0.72, showed greater diversity than each of the es-
cape-associated CD8  T cell responses (p-values range from
0.006–0.03 for each comparison), except for NS31446.
There was no significant difference between the entropy
value of each of these responses and the NS31446 response
(1.53   9.1), which was the only T cell response with a
high entropy value that was associated with viral escape
(Fig. 7 and Table I). Overall, the four responses associated
with escape from immune recognition were significantly
less diverse than those associated with resolution of infec-
tion, or that did not lead to escape from immune recogni-
tion (P   0.011).
Discussion
Although there is increasing evidence for the importance of
HCV-specific T cell responses in the resolution of HCV in-
fection, reasons for the failure of the immune system to eradi-
cate the virus and to prevent viral escape mutations are less
clear (17). The aim of this paper was to characterize the TCR
repertoire of immunodominant HCV-specific T cell responses
in chimpanzees with chronic HCV infection or after success-
fully resolved primary infection and subsequent homologous
viral rechallenge. One of our goals was to understand why
HCV-specific CTL responses that are easily detectable during
chronic HCV infection in both humans (1, 50) and chimpan-
zees (2, 11) are not capable of clearing viremia.
We observed striking differences between the T cell re-
ceptor repertoire diversity of the majority of responses that
were associated with viral escape in chronic infection and
those where no escape occurred, either in chronic or re-
solved infection. Marked diversity within the antigen-spe-
cific TCR repertoire has been noted for a variety of
chronic viral infections (20–23, 33, 43, 45, 51) including
HCV (52). However, despite the general descriptions of
TCR repertoire fluctuations over the course of viral infec-
tions (33, 43, 45) or TCR usage of individual CTL clones
(52), there has been no comprehensive analysis of the di-
versity of the antigen-specific TCR repertoire in relation
to clearance of viremia or the generation of viral escape
variants. In our analysis, three out of four T cell responses
directed against T cell epitopes in which viral escape muta-
tions developed during chronic HCV infection displayed a
highly homogeneous amino acid motif within their antigen
recognition site, and this held true for both the TCR  and
TCR  chains. A Shannon entropy analysis confirmed this
limited TCR diversity, showing decreased entropy values
at the antigen recognition sites within these TCR popula-
tions. In a longitudinal analysis, the highly homogenous
Figure 7. CDR3 entropy of
HCV-specific responses from chron-
ically infected chimpanzees CBO603
and CH-503 and chimpanzee
CBO572 after resolved HCV infec-
tion. Bars represent mean CDR3
entropy ( SD) of unselected T cells
(gray bar), HCV-specific T cell re-
sponses associated with CTL escape
(white bars), and those not associated
with CTL escape (black bars).TCR Diversity and CTL Escape 316
CDR3 repertoire was present long before the viral escape
mutation could be detected, and ruled out the possibility
this was an oligoclonal T cell expansion that occurred in
response to a mutation within the recognized epitope. It is
important to note that in each of these responses, the dom-
inant T cell clonotypes were unable or at least substantially
reduced in their capacity to recognize the variant peptides
in vitro. Furthermore, it was not possible to expand T cell
responses to these epitope variants despite repetitive pep-
tide stimulations in vitro.
Our results are unlikely to be due to a selection bias in
CD8  T cell responses with restricted TCR repertoires
(e.g., due to low frequency of epitope-specific T cells). For
example, the NS31446 response generated quite a diverse
TCR repertoire after in vitro expansion, despite the
low magnitude of the response as measured directly via
ELISPOT (unpublished data). There was also no correlation
between the magnitude of in vitro expansion of IFN-  
cells and the TCR amino diversity of epitope-specific T cell
responses in chronic infection. Although the low entropy
repertoire generated after expansion with the E2588 peptide
(Fig. 2 C) was dominated by a single clonotype, there were
several clonotypes present in this response that conformed
to a particular motif that directly corresponded to that of
liver-derived CTL clones derived several years earlier.
Therefore, these responses were comprised of many distinct
clonotypes as defined by differences in the encoding nucle-
otides (indicated by the gray areas within the nucleotide se-
quences in Figs. 1 and 2) and yet displayed a restricted TCR
repertoire at the amino acid level. This may reflect the in-
ability of new clonotypes with different CDR3 amino acid
motifs to emerge. Importantly, the restricted amino acid
variability seemed to be stable over an extended period of
time (at least 9 yr), although the emergence of different
clonotypes (with the same restricted amino acid repertoire)
could be observed over time. The observation of long-term
clonal stability in association with persistent viral replication
extends our earlier findings in human HIV infection (53,
54). However, our results indicate an inability of the im-
mune system to directly respond to the emergence of viral
mutations, and in this case a less effective immune response
is maintained over a prolonged period of time, a situation
that has been termed “original antigenic sin” (55).
In resolved infection, there was a substantial increase in
the magnitude of HCV-specific T cell responses after viral
rechallenge ( 10-fold for both the CD8  [E2445] and
CD4  T cell responses ([NS31248] evaluated here; reference
9) and, whereas the entropy of the CD8 response declined
slightly at the peak of the response, the CDR3 region en-
tropy of the CD4  T cell response evaluated after rechal-
lenge before remained diverse, despite rather restricted us-
age of the BV5 TCR gene. This association between the
ability to expand diverse TCR repertoires after T cell stim-
ulation and a favorable disease outcome may be related to
prior observations that T cells with enhanced proliferative
potential are associated with better control of viremia in
murine models (56, 57) and after HIV infection (58).
Although our paper describes the association between
TCR diversity and the emergence of viral escape mutations
during chronic HCV infection, the reasons why limited
TCR repertoires are generated in the first place cannot be
answered with our study design. The antigen-specific
TCR repertoire could be shaped by positive and negative
selection during thymopoesis (59, 60) or by overrepresen-
tation of certain nucleotides within the CDR3 region
TCR germline sequences (61). Furthermore, differences in
TCR affinity might influence a selective expansion of cer-
tain clonotypes (36, 62) as described in a previous paper
where TCR diversity was found to be associated with the
binding affinity of the peptide to its MHC class I complex
(21). Whatever the reasons may be for a reduced diversity
of antigen-specific TCR clonotypes against particular epi-
topes, we suggest that this inflexibility to substantially
change the TCR repertoire at the amino acid level might
be crucial for successful immune evasion by the virus.
But how can reduced amino acid variability within the
TCR repertoire facilitate immune evasion by the virus?
We hypothesize that reduced amino acid sequence variabil-
ity of the antigen recognition site within an HCV-specific
T cell response might result in a reduced flexibility to rec-
ognize viral sequence variations within the epitope. This
might result in better chances to evade immune recogni-
tion and thereby provide a survival benefit for the virus by
two mechanisms. First, survival might be more likely with
lack of T cell recognition itself. Evidence for this mecha-
nism has been demonstrated in chronic viral infections such
as HIV infection, where a single amino acid change in an
epitope can abrogate recognition by an individual CTL
clone, but where efficient cross-recognition of epitope
variations by diverse T cell clonotypes can be observed (34,
63). Second, we hypothesize that CD8  T cell responses
with a limited TCR repertoire might be more vulnerable
to the induction of clonal unresponsiveness due to antago-
nistic properties of the epitope variation, which has been
observed in various chronic viral infections (12–14).
For the robust, successful CD8 -mediated immune re-
sponse directed against E2445 in animal CBO572, we ob-
served a narrowing of TCR diversity after rechallenge with
HCV. This response was diverse in the memory phase and
after rechallenge; however, at the peak of the immune re-
sponse after rechallenge, the dominant TCR clonotypes
showed preferential expansion. This led to an overall de-
crease in CDR3 entropy within this population of TCR
sequences, and is consistent with a previous paper showing
TCR repertoire narrowing after rechallenge infection (21).
This would be consistent with the hypothesis that the ini-
tial generation of a diverse TCR repertoire, followed by
clearance of the pathogen, leaves behind a diverse memory
pool of T cells. After rechallenge those T cells with the
highest avidity and highest antiviral activity will preferen-
tially expand and result in more rapid viral clearance upon
rechallenge. For a polyclonal CD4  T cell response, we
observed the emergence of previously undetected clono-
types that displayed identical CDR3 amino acid sequencesMeyer-Olson et al. 317
but rearranged different yet closely related variable regions
(Fig. 6). This finding also supports the idea of a preferential
expansion of T cell clones with optimal antigen recogni-
tion that is related to the structure of the CDR3 antigen
recognition site. Interestingly, this diverse response was
characterized by preferential rearrangement of variable re-
gions belonging to the TRBV5 family, indicating that re-
striction of TRBV rearrangement does not predict the de-
gree of TCR diversity at the antigen recognition site.
The emergence of viral escape mutations within a CTL
epitope might occur within contact residues interacting
with the TCR or through mutations that affect antigen
presentation. The latter could be located within the epi-
tope, especially within MHC anchor residues, or even out-
side the epitope at positions that affect antigen processing.
With highly diverse antigen-specific TCR repertoires,
there is an increased likelihood that viral mutations that af-
fect only the peptide–TCR interaction site, and do not
completely interrupt peptide presentation or processing,
will be recognized by clonotypes within the repertoire.
Furthermore, in this case it would be unlikely that a partic-
ular virus mutation could function as an antagonist to the
entire TCR repertoire. Alternately, it has to be emphasized
that escape mutations triggered by narrow TCR repertoires
may also occur within residues critical for binding to the
MHC class I molecule. At which amino acid position the
mutation finally occurs is the result of the balance between
the impact of amino acid variation on the function/struc-
ture of the respective viral protein (viral fitness) and the ef-
ficiency of immune evasion (survival benefit). In conclu-
sion, a narrow TCR repertoire might thus be more
beneficial for the virus because it is less adaptive (cross-
reactive) to viral variations within the epitopes and, thus,
allows the virus to select for the mutations that are most
beneficial in terms of viral fitness.
For one CD8  T cell response (NS31446), we observed
an amino acid mutation that led to decreased recognition
despite a diverse TCR repertoire. This could be explained
by a mutation interfering with successful peptide presenta-
tion on the MHC class I molecule. If there are constraints
on particular viral epitopes that prevent the generation of
variants that completely abrogate MHC class I binding or
interfere with antigen processing, it may still be advanta-
geous for the host to generate a diverse TCR repertoire. In
this case, the generation of a broad array of T cell clones
may include T cell receptors with high affinity for the pep-
tide MHC complex, and this may to some extent compen-
sate for reduced binding to MHC class I.
The finding of highly similar TCR repertoires of anti-
gen-specific T cells in different compartments, liver and
peripheral blood, is in accordance with recent findings in a
murine model of a localized viral infection (64). Our find-
ings of similar TCR motifs as well as similar degrees of
TCR diversity between T cell clones isolated from the
liver and T cells specific for the same antigen isolated from
peripheral blood also suggest that virus selection pressure is
mediated by T cells homing to the site of infected cells and
then entering the peripheral circulation. This argues against
views that peripheral blood and liver might act as com-
pletely different immunological compartments, at least for
immune responses characterized by an oligoclonal TCR
repertoire. However, future studies will be needed to ad-
dress whether there are quantitative differences between
the two compartments.
In summary, we provide evidence that the amino acid di-
versity within the T cell receptor CDR3 antigen recognition
site may have direct effects on the evolution of escape muta-
tions within viral epitopes, and, therefore, might be a crucial
factor for the outcome of chronic viral infections such as
HCV or HIV, where viral escape mutations contribute to im-
mune evasion. Further studies such as these will be critical to
our understanding of the molecular basis of viral immunity.
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